Basic and translational research on proteinase-activated receptors: Implication of proteinase/proteinase-activated receptor in gastrointestinal inflammation

Journal of Pharmacological Sciences

Volumn 108, Issue 4, 2008, Pages 415-421

  Yoshida, Norimasa ^a,b   Yoshikawa, Toshikazu ^b  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Colitis; Esophagitis; Helicobacter pylori; Proteinase inhibitor; Proteinase activated receptor (PAR)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NAFAMSTAT MESILATE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; TRANSCRIPTION FACTOR AP 1; TRYPSIN; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; CELL ACTIVATION; COLITIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENZYME ACTIVATION; ESOPHAGITIS; ESOPHAGUS MUCOSA; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; REFLUX ESOPHAGITIS; STOMACH MUCOSA; ULCERATIVE COLITIS;

EID: 58149165209     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08R31FM     Document Type: Conference Paper

References (48)

1. Couglin SR. Thrombin signaling and protease-activated receptors. Nature. 2000;407:258-264.
2. Vergnolle N, Wallece JL, Bunnet NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci. 2001;22:146-152.
3. 2 release from human respiratory epithelial cells. J Immunol. 2002;168:3577-3585.
4. Johansson U, Lawson C, Dabare M, Syndercombe-Court D, Newland AC, Howells GL, et al. Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1beta. J Leukoc Biol. 2005;78:967-975.
5. Saifeddine M, Al-Ani B, Cheng C, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissues. Br J Pharmacol. 1996;118:521-530.
6. Vergnolle N, Hollenberg MD, Sharkey K, Wallace JL. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw. Br J Pharmacol. 1999;127:1083-1090.
7. Vergnolle N. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol. 1999;163:5064-5069.
8. Ossovkaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84:579-621.
9. Kawabata A, Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J pharmacol. 2000;82:171-174.
10. Kawabata A. Gastrointestinal functions of protease-activated receptors. Life Sci. 2003;74:247-254.
11. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ, et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 2002;50:451-459.
12. Yoshida N, Yoshikawa T. Defense mechanism of the esophageal mucosa and esophageal inflammation. J Gastroenterol. 2003;38:31-34.
13. Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol. 2003;98:551-556.
14. Yoshida N, Uchiyama K, Kuroda M, Sakuma K, Kokura S, Ichikawa H, et al. IL-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2004;39:816-822.
15. Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr. 2007;40:13-23.
16. Yoshida N, Katada K, Handa O, Takagi T, Kokura S, Naito Y, et al. IL-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med. 2007;19:335-340.
17. Yoshida N, Imamoto K, Uchiyama K, Kuroda M, Naito Y, Mukaida N, et al. Molecular mechanisms involved in IL-8 production by normal human esophageal epithelial cells. Aliment Pharmacol Ther. 2006;24 Suppl 4:219-226.
18. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799-1809.
19. Crabtree JE, Farmerry SM, Lindley IJ, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol. 1994;47:945-950.
20. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakabe H, Ohmoto Y, et al. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun. 1997;65:3218-3224.
21. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328-1333.
22. Kassai K, Yoshikawa T, Yoshida N, Hashiramoto A, Kondo M, Murase H. Helicobacter pylori water extract induces interleukin-8 production by gastric epithelial cells. Dig Dis Sci. 1999;44:237-242.
23. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K. Type 1 Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cell. Infect Immun. 2001;69:4382-4389.
24. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002;123:414-424.
25. Takenaka R, Yokota K, Ayada K, Mizuno M, Zhao Y, Fujinami Y, et al. H. pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology. 2004;150:3913-3922.
26. Kajikawa H, Yoshida N, Katada K, Hirayama F, Handa O, Kokura S, et al. Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion. 2007;76:248-255.
27. Bumann D, Aksu S, Wendland M, Janek K, Zimny-Arndt U, Sabarth N, et al. Proteome analysis of secreted proteins of gastric pathogen Helicobacter pylori. Infect Immun. 2002;70:3396-3403.
28. Sassoon N, JP Arie, JM Betton. PDZ domains determine the native oligomeric structure of DegP (HtrA) protease. Mol Microbiol. 1999;33:583-589.
29. Spiess C, Beil A, Ehrmann M. A temperature-dependent switch from chaperone to protease in widely conserved heat shock protein. Cell. 1999;97:339-347.
30. Hirata I, Yoshida N, Omatsu T, Okayama T, Suzuki T, Kajikawa H, et al. The possible involvement of protease-activated receptors (PARs) in H. pylori-associated gastritis. Gastroenterology. 2008;134 Suppl 1:A566-A567.
31. Toyoda N, Gabazza EC, Inoue H, Araki K, Nakashima S, Oka S, et al. Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol. 2003;38:253-259.
32. Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H, et al. The pretease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest. 2001;107:1443-1450.
33. Kawao N, Sakaguchi Y, Tagome A, Kuroda R, Nishida S, Irimajiri K, et al. Protease-activated receptor-2 in the rat gastric mucosa: immunolocalization and facilitation of pepsin /pepsinogen secretion. Br J Pharmacol. 2002;135:1292-1296.
34. Abraham WM. Tryptase: potential role in air way inflammation and remodeling. Am J Physiol Lung Cell Mol Physiol. 2002;282:L193-L196.
35. He SH, Walls AF. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol. 1997;328:89-97.
36. He SH, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol. 1997;159:6216-6225.
37. Temkin V, Kantor B, Weg V, Hartman ML. Tryptase activates the mitogen-activated protein kinase/active protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol. 2002;169: 2662-2669.
38. Raithel M, Winterkamp S, Pacurar A, Vlrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:174-179.
39. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol. 2002;161:1903-1915.
40. Cenac N, Garcia-Villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, et al. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol. 2003;170:4296-4300.
41. Tremaine WJ, Brezezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16:407-413.
42. Mori S, Itoh Y, Shinohata R, Sendo T, Oishi R, Nishibori M. Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J Pharmacol Sci. 2003;92:420-423.
43. Sendo T, Itoh Y, Goromaru T, Sumimura T, Saito M, Aki K, et al. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol. 2003;138:959-967.
44. Isozaki Y, Yoshida N, Kuroda M, Handa O, Takagi T, Kokura S, et al. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis. Scand J Gastroenterol. 2006;41:944-953.
45. Yoshida N, Isozaki Y, Takagi T, Takenaka S, Uchikawa R, Arizono N, et al. Review article: anti-tryptase therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24 Suppl 4:249-255.
46. Moriss GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795-803.
47. Yoshida N, Yoshikawa T, Yamaguchi T, Naito Y, Tanigawa T, Murase H, et al. A novel water-soluble vitamin E derivative protects against experimental colitis in rats. Antioxid Redox Signal. 1999;1:555-562.
48. Sutherland L, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, protosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898.